{"transactions":[{"id":888410,"issuer":{"id":8506,"kind":"organization","name":"Silexion Therapeutics Corp"},"owners":[{"id":65207,"kind":"person","name":"Peled Amnon","position":1,"cik":"0002048879","reported_name":"Peled Amnon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Ordinary Shares)","published_at":"2026-02-23T16:11:15.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":8904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this row consists of the grant to the Reporting Person by the Issuer of options to purchase ordinary shares, which grant was approved by the Issuer's board of directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options reported in this row vest in their entirety on the one-year anniversary of, and expire on the ten-year anniversary of, the date of approval of their grant by the Issuer's board of directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The options reported in this row vest in their entirety on the one-year anniversary of, and expire on the ten-year anniversary of, the date of approval of their grant by the Issuer's board of directors."}],"balance_after":8904,"derivative":{"exercise_price":1.65,"exercise_date":"2027-02-12","expiration_date":"2036-02-12","underlying":"Ordinary Shares","underlying_shares":8904},"source":{"system":"sec-edgar","filing":"0001178913-26-000596","document":"zk2634424.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2048879/000117891326000596/zk2634424.xml","form_type":"4"}},{"id":888409,"issuer":{"id":8506,"kind":"organization","name":"Silexion Therapeutics Corp"},"owners":[{"id":65207,"kind":"person","name":"Peled Amnon","position":1,"cik":"0002048879","reported_name":"Peled Amnon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-02-23T16:11:15.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":7576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this row consists of the grant to the Reporting Person by the Issuer of fully vested restricted share units (RSUs), which were immediately settled for underlying ordinary shares, par value $0.0135 per share, of the Issuer (\"ordinary shares\"), in respect of the Reporting Person's director services to the Issuer. The grant was approved by the Issuer's board of directors."}],"balance_after":8237,"source":{"system":"sec-edgar","filing":"0001178913-26-000596","document":"zk2634424.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048879/000117891326000596/zk2634424.xml","form_type":"4"}},{"id":956667,"issuer":{"id":8506,"kind":"organization","name":"Silexion Therapeutics Corp"},"owners":[{"id":65207,"kind":"person","name":"Peled Amnon","position":1,"cik":"0002048879","reported_name":"Peled Amnon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy Ordinary Shares)","published_at":"2025-12-31T13:00:13.000Z","date":"2025-02-09","kind":"grant","planned":false,"acquired":true,"shares":780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of options to purchase ordinary shares, and underlying ordinary shares, reported in this row have been adjusted downwards, and the exercise price of those options has been adjusted proportionately upwards, to reflect the 1-for-15 reverse share split effected by the Issuer on July 29, 2025."},{"field":"shares","element":"transactionShares","label":"F3","text":"The number of options to purchase ordinary shares, and underlying ordinary shares, reported in this row have been adjusted downwards, and the exercise price of those options has been adjusted proportionately upwards, to reflect the 1-for-15 reverse share split effected by the Issuer on July 29, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the stock options reported in this row vest (and become exercisable) on the first anniversary of the grant date (i.e., on February 9, 2026), subject to the Reporting Person's continued service through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options to purchase ordinary shares, and underlying ordinary shares, reported in this row have been adjusted downwards, and the exercise price of those options has been adjusted proportionately upwards, to reflect the 1-for-15 reverse share split effected by the Issuer on July 29, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of options to purchase ordinary shares, and underlying ordinary shares, reported in this row have been adjusted downwards, and the exercise price of those options has been adjusted proportionately upwards, to reflect the 1-for-15 reverse share split effected by the Issuer on July 29, 2025."}],"balance_after":780,"derivative":{"exercise_price":18.9,"exercise_date":"2026-02-09","expiration_date":"2035-02-09","underlying":"Ordinary Shares","underlying_shares":780},"source":{"system":"sec-edgar","filing":"0001178913-25-004143","document":"zk2534150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2048879/000117891325004143/zk2534150.xml","form_type":"4"}},{"id":956666,"issuer":{"id":8506,"kind":"organization","name":"Silexion Therapeutics Corp"},"owners":[{"id":65207,"kind":"person","name":"Peled Amnon","position":1,"cik":"0002048879","reported_name":"Peled Amnon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-31T13:00:13.000Z","date":"2025-02-09","kind":"grant","planned":false,"acquired":true,"shares":661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents ordinary shares underlying RSUs granted to the Reporting Person by the Issuer, as consideration for the Reporting Person's service on the Issuer's board of directors. The shares subject to this award vest in full on the first anniversary of the grant date (i.e., on February 9, 2026), subject to the Reporting Person's continued service through such date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents ordinary shares underlying RSUs granted to the Reporting Person by the Issuer, as consideration for the Reporting Person's service on the Issuer's board of directors. The shares subject to this award vest in full on the first anniversary of the grant date (i.e., on February 9, 2026), subject to the Reporting Person's continued service through such date."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of ordinary shares reported in this row has been adjusted retroactively to reflect a 1-for-15 reverse share split effected by the Issuer on July 29, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of ordinary shares reported in this row has been adjusted retroactively to reflect a 1-for-15 reverse share split effected by the Issuer on July 29, 2025."}],"balance_after":661,"source":{"system":"sec-edgar","filing":"0001178913-25-004143","document":"zk2534150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048879/000117891325004143/zk2534150.xml","form_type":"4"}}]}